Non-Invasive Biophoton Therapy Restores Visual Function in Advanced Glaucoma: A Human and Canine Case Report

Authors

  • James Z Liu First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA Author
  • Laura Poirier First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA Author
  • Jonathan Louie First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA Author
  • Helen Y Gu First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA Author

DOI:

https://doi.org/10.47363/JNRRR/2025(7)231

Keywords:

Biophoton Therapy, Glaucoma, Vision Restoration, Photobiomodulation, Optic Nerve Regeneration, Retinal Ganglion Cells, Mitochondrial Dysfunction, Non-Invasive Neurotherapy, Canine Glaucoma Model, Near-Infrared Light

Abstract

Background: Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive retinal ganglion cell loss and optic nerve degeneration. Current therapies focus on lowering intraocular pressure but do not reverse established visual deficits. Novel, non-invasive approaches aimed at neuroregeneration are urgently needed.

Objective: To explore the potential of biophoton therapy a non-pharmacologic intervention delivering light in the 500-1000 nm range to restore visual function in cases of advanced glaucoma.

Methods: Two real-world case observations were documented: a human patient with a history of five glaucoma surgeries and 50% vision loss in one eye, and a canine diagnosed with secondary glaucoma and complete functional blindness. Both subjects received biophoton therapy via a non-heating biophoton-emitting eye mask (human) or stationary biophoton generators placed near the sleeping area (canine). No additional pharmacologic or surgical interventions were introduced during the observation period.

Results: Within four weeks of nightly biophoton eye mask use, the human subject reported complete resolution of visual fog and restoration of color perception and brightness in the affected eye. The canine subject demonstrated regained visual tracking and environmental navigation within two weeks of therapy, despite an initial prognosis of irreversible blindness. In both cases, the improvements occurred in the absence of medication changes or additional treatments.

Conclusion: These findings suggest that biophoton therapy may stimulate visual recovery in cases of advanced glaucoma, potentially through mechanisms involving mitochondrial activation, neuroprotection, and improved microcirculation. While anecdotal, the observed cross-species visual restoration supports the biological plausibility of biophoton-mediated optic nerve regeneration. Controlled clinical studies are warranted to systematically evaluate efficacy, dose-response, and mechanisms of action.

Author Biographies

  • James Z Liu, First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

    First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

  • Laura Poirier, First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

    First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

  • Jonathan Louie, First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

    First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

  • Helen Y Gu, First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

    First Institute of All Medines, 1000 Uniwema Blvd, New Castle, DE 19720, USA

Downloads

Published

2025-08-20

Issue

Vol. 7 No. 8 (2025): Volume 7 Issue 8

Section

Articles